226 related articles for article (PubMed ID: 25455739)
1. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
[TBL] [Abstract][Full Text] [Related]
2. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
Salem B; Miner S; Hensel NF; Battiwalla M; Keyvanfar K; Stroncek DF; Gee AP; Hanley PJ; Bollard CM; Ito S; Barrett AJ
Cytotherapy; 2015 Dec; 17(12):1675-86. PubMed ID: 26422657
[TBL] [Abstract][Full Text] [Related]
3. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
Lin W; Oh SK; Choo AB; George AJ
Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
[TBL] [Abstract][Full Text] [Related]
4. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
5. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
[TBL] [Abstract][Full Text] [Related]
6. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
Zhou Y; Day A; Haykal S; Keating A; Waddell TK
Cytotherapy; 2013 Oct; 15(10):1195-207. PubMed ID: 23845188
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function].
Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
[TBL] [Abstract][Full Text] [Related]
11. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
14. Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells.
Burand AJ; Di L; Boland LK; Boyt DT; Schrodt MV; Santillan DA; Ankrum JA
Front Immunol; 2020; 11():143. PubMed ID: 32158443
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs).
Hsu PJ; Liu KJ; Chao YY; Sytwu HK; Yen BL
J Vis Exp; 2015 Dec; (106):e53265. PubMed ID: 26780482
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
Engela AU; Baan CC; Litjens NH; Franquesa M; Betjes MG; Weimar W; Hoogduijn MJ
Clin Exp Immunol; 2013 Dec; 174(3):449-58. PubMed ID: 24028656
[TBL] [Abstract][Full Text] [Related]
17. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
18. Placenta-Derived Mesenchymal Stem Cells Reduce the Interleukin-5 Level Experimentally in Children with Asthma.
Lin SC; Liou YM; Ling TY; Chuang YH; Chiang BL
Int J Med Sci; 2019; 16(11):1430-1438. PubMed ID: 31673233
[No Abstract] [Full Text] [Related]
19. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
20. Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use.
Torrents S; Del Moral AE; Codinach M; Rodríguez L; Querol S; Vives J
Immunol Res; 2023 Oct; 71(5):725-734. PubMed ID: 37120479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
